Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;5(9):e191460.
doi: 10.1001/jamaoncol.2019.1460. Epub 2019 Sep 12.

National and State Estimates of Lost Earnings From Cancer Deaths in the United States

Affiliations

National and State Estimates of Lost Earnings From Cancer Deaths in the United States

Farhad Islami et al. JAMA Oncol. .

Abstract

Importance: Information on the economic burden of cancer mortality can serve as a tool in setting policies and prioritizing resources for cancer prevention and control. However, contemporary data are lacking for the United States nationally and by state.

Objective: To estimate lost earnings due to death from cancer overall and for the major cancers in the United States nationally and by state.

Design, setting, and participants: Person-years of life lost (PYLL) were calculated using numbers of cancer deaths and life expectancy data in individuals aged 16 to 84 years who died from cancer in the United States in 2015. The annual median earnings in the United States were used to assign a monetary value for each PYLL by age and sex. Cancer mortality and life expectancy data were obtained from the National Center for Health Statistics and annual median earnings from the US Census Bureau's 2016 Current Population Survey's March Annual Social and Economic Supplement. Data analysis was performed from October 22, 2018, to February 25, 2019.

Main outcomes and measures: Lost earnings due to cancer death, represented as estimated future wages in the absence of premature death.

Results: A total of 8 739 939 person-years of life were lost to cancer death in persons aged 16 to 84 years in the United States in 2015, translating to lost earnings of $94.4 billion (95% CI, $91.7 billion-$97.3 billion). For individual cancer sites, lost earnings were highest for lung cancer ($21.3 billion), followed by colorectal ($9.4 billion), female breast ($6.2 billion), and pancreatic ($6.1 billion) cancer. Age-standardized lost earning rates per 100 000 were lowest in the West and highest in the South, ranging from $19.6 million (95% CI, $19.1 million-$20.2 million) in Utah to $35.3 million ($34.4 million-$36.3 million) in Kentucky. Approximately 2.4 million PYLL and $27.7 billion (95% CI, $26.9 billion-$28.5 billion) in lost earnings (29.3% of total that occurred in 2015) would have been avoided in 2015 if all states had the same age-specific PYLL or lost earning rates as Utah.

Conclusions and relevance: Our findings indicate large state variation in the economic burden of cancer and suggest the potential for substantial financial benefit through delivery of effective cancer prevention, screening, and treatment to minimize premature cancer mortality in all states.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The authors are employed by the American Cancer Society, which received a grant from Merck Inc for intramural research outside the submitted work; however, their salaries are solely funded through the American Cancer Society. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Age-Standardized Lost Earning Rates (Million Dollars per 100 000) Owing to Death From All Cancers Combined and Lung Cancer in Persons Aged 16 to 84 Years by Sex and State, 2015
Lost earning rates are age-adjusted to the 2000 US standard population.
Figure 2.
Figure 2.. Age-Standardized Lost Earning Rates (Million Dollars per 100 000) Owing to Death From Selected Major Cancers in Persons Aged 16 to 84 Years in Both Sexes Combined by State, 2015
Lost earning rates are age-adjusted to the 2000 US standard population; IHBD indicates intrahepatic bile duct.

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):-. doi:10.3322/caac.21551 - DOI - PubMed
    1. Yabroff KR, Lund J, Kepka D, Mariotto A. Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev. 2011;20(10):2006-2014. doi:10.1158/1055-9965.EPI-11-0650 - DOI - PMC - PubMed
    1. Ekwueme DU, Chesson HW, Zhang KB, Balamurugan A. Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis—United States, 2003. Cancer. 2008;113(10)(suppl):2936-2945. doi:10.1002/cncr.23761 - DOI - PubMed
    1. Bradley CJ, Yabroff KR, Dahman B, Feuer EJ, Mariotto A, Brown ML. Productivity costs of cancer mortality in the United States: 2000-2020. J Natl Cancer Inst. 2008;100(24):1763-1770. doi:10.1093/jnci/djn384 - DOI - PMC - PubMed
    1. Hanly P, Pearce A, Sharp L. The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Rev Pharmacoecon Outcomes Res. 2014;14(3):355-377. doi:10.1586/14737167.2014.909287 - DOI - PubMed